Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight ...

Delhi High Court bars Dr Reddy's and OneSource from selling semaglutide in India, supporting Novo Nordisk's patent rights as ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

Kumar emphasized the importance of working with a physician to choose a weight-loss medication that matches the patient’s personal goals and health status. "Both Wegovy and Zepbound have ...

Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?

Viking Therapeutics has key trial catalysts ahead and trades near biotech deal valuations, despite dilution risks. Find out ...

The Danish drugmaker Novo Nordisk announced it has temporarily reduced the price of the weight-loss drug Wegovy for new customers as it attempts to limit sales of compounded versions of the ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.